Preferred Label : Empliciti;
Origin ID : M000613222;
Related record
https://www.has-sante.fr/jcms/p_3406109/fr/empliciti-elotuzumab-myelome-multiple-en-rechute-et-refractaire
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
Empliciti
elotuzumab
multiple myeloma
Refractory Multiple Myeloma
Recurrent Multiple Myeloma
elotuzumab
antineoplastic agents
infusions, intravenous
Dexamethasone/Elotuzumab/Pomalidomide Regimen
---
